Matt Brockmeier
Focused on the law, business, policy, and sometimes even the politics of drugs.
Corporate Law | Regulatory | Healthcare | Cannabis | Psychedelics
01.
The Musician.Plays guitar and saxophone, and enjoys live music as often as possible.
02.
The Traveller.Enjoys new places, especially ones where he can practice French and Spanish
03.
The Athlete.Prefers to be outside. Enjoys yoga, cycling, and camping. for mutual growth.
04.
The Fixer.Restores vintage British cars, woodworking and handy work.
Oxford University, Anglo-American Legal Systems, 2005
The Ohio State University, Bachelor of Arts, 2006
DePaul University College of Law, Juris Doctor; Certificate in Health Law, 2009
Universidad Católica Argentina, Latin American Business Law, 2009
Matt began his career in Chicago with a national law firm, where he navigated layers of insurance coverage in multi-million dollar multi-state commercial litigation.
Following a brief time crafting policy in DC, Matt relocated to Denver, where he assumed a number of health-industry focused roles. He was a member of the healthcare practice group of an AmLaw100 firm, assistant general counsel to a health insurance company, and practiced corporate and regulatory law with a prominent boutique cannabis law firm before joining Antithesis.
His current practice primarily involves the law, business, policy, and (sometimes even) politics of drugs. Specifically, he focuses on psychedelics, cannabis, and other controlled substances, both in the context of healthcare/ wellness as well as drug policy reform.
Illinois
Colorado
Psychedelic Bar Association, Board Member
Natural Medicine Advisory Board Sub Committee on Public Health & Health Equity
International Cannabis Bar Association
American Health Lawyers Association
Formed a Public Benefit Company collective for ketamine practitioners (including practice management, referrals, and insurance) along with related fundraising documents.
Advised out of state ketamine practitioner on application for Colorado facilitator license and formation of entity through which to operate Colorado therapy practice, including telehealth and licensure issues.
Assisted functional mushroom and superfood startup with entity formation, regulatory compliance, and business advisory services related to entry into regulated psilocybin market in Colorado review and drafting of licensing agreements.
Formed a nonprofit entity for psychedelic education platform focused on oncology end of life care.
Certified in Healthcare Compliance, Compliance Certification Board (July 2017)
Editor, DePaul Journal of Healthcare Law (2008-09)
Guest, “Becker’s Healthcare/ Private Equity & Business” Podcast (September 2025)
Speaker, “McGuireWoods HealthcareGO” Conference, Charlotte, NC (September 2025)
Speaker, “Society of Cannabis Clinicians’ 3rd Annual Medical Cannabis Conference, Denver (October 2025)
Guest, McGuireWoods’ “The Corner Series” with Geoff Cockrell (October 2025)
Guest, Roots to Risk, From Education to Legislation: Unlocking the Potential of Psychedelics in Society, AlphaRoot Podcast (July 2023)
Author, Social Impact Primer, Psychedelic Bar Association (February 2023)
Speaker, “Navigating Psychedelic Frontiers: A Policy Panel on Colorado’s Natural Medicine Health Act,” Arctic Visions (August 2024)
Speaker, “Psychedelics: The Beginning of the End of the Drug War,” INCBA Cannabis Law Institute (July 2024)
Speaker, “PBA Sessions: Insurance, Risk & Liability,” MAPS Psychedelic Science Conference (June 2023)
Speaker, “NMHA: An Evolving Legal Landscape,” Psycon Psychedelic Convention (September 2023)
Quoted, “Are ‘Ketamine Bros’ Really the Biggest Problem in the Psychedelic Movement?,” The Psychedelic Pulse (July 2024)
Quoted, “This Veteran-Founded Church Wants to Sell Psychedelics At Your Local Drug Store,” DoubleBlind (October 2023)
Author, Of Consulting and Counseling: Hybrid Roles of Lawyers and Consultants, The Art of Advice (2014)